Oncolytics Biotech, Inc. (ONCY)
0.8432
-0.01
(-1.55%)
USD |
NASDAQ |
Sep 04, 16:00
0.8417
0.00 (0.00%)
After-Hours: 20:00
Oncolytics Biotech SG&A Expense (TTM) : 16.62M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.62M |
| March 31, 2026 | 13.60M |
| December 31, 2025 | 10.90M |
| September 30, 2025 | 11.50M |
| June 30, 2025 | 9.180M |
| March 31, 2025 | 9.544M |
| December 31, 2024 | 9.724M |
| September 30, 2024 | 10.02M |
| June 30, 2024 | 11.65M |
| March 31, 2024 | 11.77M |
| December 31, 2023 | 11.92M |
| September 30, 2023 | 11.54M |
| June 30, 2023 | 9.462M |
| March 31, 2023 | 9.112M |
| December 31, 2022 | 8.804M |
| September 30, 2022 | 9.098M |
| June 30, 2022 | 9.558M |
| March 31, 2022 | 10.20M |
| December 31, 2021 | 10.63M |
| September 30, 2021 | 10.71M |
| June 30, 2021 | 10.27M |
| March 31, 2021 | 9.607M |
| December 31, 2020 | 7.642M |
| September 30, 2020 | 7.695M |
| June 30, 2020 | 7.236M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.381M |
| December 31, 2019 | 7.213M |
| September 30, 2019 | 5.881M |
| June 30, 2019 | 5.615M |
| March 31, 2019 | 5.539M |
| December 31, 2018 | 5.585M |
| September 30, 2018 | 5.484M |
| June 30, 2018 | 5.405M |
| March 31, 2018 | 5.210M |
| December 31, 2017 | 4.800M |
| September 30, 2017 | 4.463M |
| June 30, 2017 | 4.355M |
| March 31, 2017 | 4.154M |
| December 31, 2016 | 4.162M |
| September 30, 2016 | 3.95M |
| June 30, 2016 | 3.912M |
| March 31, 2016 | 4.195M |
| December 31, 2015 | 4.158M |
| September 30, 2015 | 4.146M |
| June 30, 2015 | 4.263M |
| March 31, 2015 | 4.216M |
| December 31, 2014 | 4.524M |
| September 30, 2014 | 4.611M |
| June 30, 2014 | 4.771M |
| March 31, 2014 | 4.952M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 172.57M |
| Sangamo Therapeutics, Inc. | 31.64M |
| Sarepta Therapeutics, Inc. | 436.74M |
| Anixa Biosciences, Inc. | 6.118M |
| Vicapsys Life Sciences, Inc. | -0.0004M |